Beta-Alanine

What is beta-alanine and what does it do in the body?

Beta-alanine is an amino acid that is not incorporated into the body’s proteins and is the rate-limiting precursor of carnosine (a dipeptide made of histidine and beta-alanine) synthesis in skeletal muscle. Carnosine buffers the effect on pH of hydrogen ions, a product of anaerobic glycolysis that supplies energy in high-intensity exercise; more carnosine in muscle may blunt the pH drop in intense effort to a greater degree and may improve performance in short-to-medium duration intense efforts such as rowing and swimming. ^[1]

Beta-alanine is also made in the liver and is found in small amounts in meat, poultry, and fish. According to NIH ODS, estimated dietary intake is zero in vegans and about 1 g per day in heavy meat eaters. Carnosine itself is found in foods (beef, pork), but when taken by mouth it is broken down into its component amino acids and is therefore inefficient at raising muscle carnosine; beta-alanine, on the other hand, reliably raises muscle carnosine. ^[1]

Does beta-alanine raise muscle carnosine?

According to ISSN, four weeks of supplementation with 4–6 g of beta-alanine per day raises muscle carnosine levels significantly and functions as an intracellular pH buffer. ^[2] NIH ODS reports that 4–6 g for 10 weeks can raise muscle carnosine by up to 80%, particularly in trained athletes, but that the response varies greatly: in a study in which young, physically active but untrained men took 4.8 g per day for 5–6 weeks, the increase in muscle carnosine varied between 2% and 69% at the end of 9 weeks of follow-up. In low responders, the return of beta-alanine levels to baseline (washout time) was shorter than in half of the high responders (6 weeks and 15 weeks). ^[1] This tissue-level result does not map one-to-one onto a change in performance.

Does beta-alanine improve high-intensity exercise performance?

The 2017 systematic review and meta-analysis by Saunders and colleagues combined 40 double-blind, placebo-controlled studies (65 different exercise protocols, 70 exercise measures, 1,461 participants); crossover studies were excluded because of the long washout time of muscle carnosine. The overall effect size was 0.18 (95% CI 0.08–0.28). Exercise duration determined the effect significantly (p=0.004); in 0.5–10 minute efforts the effect was 0.4998 (CI 0.246–0.753) for exercise capacity and 0.1078 (CI −0.201 to 0.416) for exercise performance, meaning that the confidence interval included zero in performance tests. Training level (p=0.559), intermittent or continuous effort (p=0.436), and total amount consumed (p=0.438) did not change the effect. ^[3]

The older meta-analysis by Hobson and colleagues, which describes itself as preliminary, covered 15 publications (360 participants); the median effect size was 0.374 in the beta-alanine groups and 0.108 in the placebo groups (p=0.002). Exercise capacity improved (p=0.013), exercise performance did not (p=0.204). Exercise of 60–240 seconds (p=0.001) and exercise longer than 240 seconds (p=0.046) improved; there was no benefit in exercise shorter than 60 seconds (p=0.312). The median effect was an improvement of 2.85% (−0.37% to 10.49%) in the exercise measure with a total median of 179 g of beta-alanine consumed. ^[4]

Set against these two reviews, a 10-study (243 people) meta-analysis published in Biology of Sport in 2024, comparing sodium bicarbonate and beta-alanine together and separately, found no ergogenic effect for beta-alanine alone (SMD 0.18; 95% CI −0.06 to 0.43; p=0.13; I² 0%). ^[5] The point estimate is the same as Saunders’ (0.18); the difference lies in the confidence interval, and this analysis rests on 10 studies rather than 40. That the effect is small is common to all three reviews; statistical significance varies by review.

NIH ODS summarizes the conflict as follows: ISSN states that 4–6 g of beta-alanine per day (for at least 2–4 weeks) can improve performance in high-intensity exercise lasting longer than 60 seconds, particularly in tasks that continue to exhaustion, but that the benefit is more modest in tests longer than 4 minutes. In contrast, a U.S. Department of Defense–supported review concluded that the limited evidence from 20 human studies does not support the use of beta-alanine for performance or recovery in active adults. The same NIH text reports that the AND/DC/ACSM position paper says it improves performance in 60–240 second high-intensity exercise, that ISSN concluded it improves performance and reduces neuromuscular fatigue, and that the Australian Institute of Sport supports its use in appropriate competitions and under the supervision of a sports physician. ^[1]

When does the effect appear and how long does it last?

According to the ISSN assessment reported by NIH ODS, the benefit increases after four weeks; muscle carnosine levels rise by 40–60% in this period. In a study in young, untrained men, the time for values to return to baseline (washout) after beta-alanine was stopped was shorter in low responders than in half of the high responders (6 weeks and 15 weeks). ^[1] In the meta-analyses, total amount consumed did not change the effect significantly (p=0.438); NIH ODS also states that no consistent relationship has been found between dose and performance effect. ^{[3] [1]} That is, the assumption that “more beta-alanine means more performance” has not been confirmed in these studies.

For whom does beta-alanine come into consideration?

NIH ODS states that beta-alanine may provide a small benefit in short-to-medium duration intense efforts (such as rowing, swimming, and team sports involving repeated sprints and intermittent efforts), whereas other studies found no benefit. ^[1] As for dietary sources, estimated intake is zero in vegans; the body also makes beta-alanine in the liver. ^[1]

Does beta-alanine work for endurance and strength?

According to NIH ODS, the evidence on whether beta-alanine consumption improves performance in endurance activities such as cycling is conflicting; experts have not reached consensus on whether the benefit is seen mainly in trained athletes or in recreationally active people, and no consistent relationship between dose and performance effect has been shown. ^[1] The ISSN position paper states that more research is needed on the effects on strength, on endurance performance over 25 minutes, and on other health benefits associated with carnosine; the same document also reports that beta-alanine reduces neuromuscular fatigue, particularly in older adults. ^[2] For this reason, muscle growth or strength gain is not a confirmed claim in this area.

Is beta-alanine more effective together with sodium bicarbonate?

In the Saunders meta-analysis, use together with sodium bicarbonate gave the largest effect size versus placebo (0.43; 95% CI 0.22–0.64). ^[3] In the 2024 meta-analysis, the combination gave an SMD of 0.32 (95% CI 0.07–0.57; p=0.02); beta-alanine (0.18) and bicarbonate (0.17) alone did not show a significant effect, but in meta-regression there was no difference between the two single agents. According to this review’s conflict-of-interest statement, the last author had previously received research support and free product from a beta-alanine manufacturer. ^[5] That is, the two meta-analyses point toward the combination giving a more favorable result; the number of combination studies is small.

Is beta-alanine safe, and why does it cause tingling?

According to ISSN, beta-alanine appears safe at recommended doses in healthy people; the only side effect reported is paresthesia, and it can be reduced with divided low doses (1.6 g) or a sustained-release formulation. ^[2] NIH ODS states that doses of 1.6–6.4 g/day appear safe for up to 8 weeks, but that a conventional dose of at least 800 mg or an amount exceeding 10 mg/kg can cause moderate to severe paresthesia; this sensation is a tingling, pricking, or burning feeling in the face, neck, back of the hands, and upper trunk, typically lasts 60–90 minutes, and is not a painful, serious, or harmful reaction. Itching has also been reported in some studies, with severity not stated. No safety data exist for use longer than one year. ^[1]

In a small randomized double-blind study with a high-amount sustained-release formulation (10 participants in the treatment group, 9 in the placebo group; mean age 22.5 ± 3.3; 15 g per day divided into three doses, 30 days), paresthesia was mostly in the form of tickling and stayed below 3/10 on the visual analog scale in almost all participants. In the beta-alanine group, serum triglycerides, LDL cholesterol, and blood urea nitrogen rose from baseline, but there was no difference from the control group; the authors state that more studies are needed on blood parameters with long-term high intake. ^[6]

Beta-alanine supplements in Türkiye

Approval from the Ministry of Agriculture and Forestry is mandatory for every dietary supplement to be marketed in Türkiye. ^[7] In the Restricted Substances List for Dietary Supplements (last updated September 21, 2026), the beta-alanine row is of chemical or enzymatic synthesis origin and carries a value of at most 6.4 g/day in the age 11 and over column (published May 2, 2016); no value is entered in the 4–10 year columns. ^[8] The 4–6 g/day range used in studies and the 1.6–6.4 g/day range that NIH ODS found safe fall within this list limit; however, this is a comparison of ranges, not a recommendation. The 15 g/day amount in the small study with the sustained-release formulation, on the other hand, is above the list limit. ^{[2] [1] [8] [6]}

Who should be cautious?

• People sensitive to tingling: According to NIH ODS, moderate to severe paresthesia can occur with conventional doses of 800 mg and above; divided doses and the sustained-release form have reduced it. ^[1]
• People considering use for longer than one year: No safety data exist for this period. ^[1]
• Competitive athletes: NIH ODS notes that products marketed for bodybuilding are adulterated with undeclared steroids and prescription drugs, which can lead to doping sanctions. ^[1]
• Ages 4–10: The Restricted Substances List has not entered a value for this age. ^[8]

Evidence table: claim, population, and limits

This guide does not recommend personal doses or treatment; in regular medication use and chronic disease, the decision depends on individual clinical assessment.